Median Survival Rate Nearly Doubles Combining Inotuzumab with Chemotherapy
Hagop M. Kantarjian, MD of MD Anderson Cancer Center's Department of Leukemia states the <br />median survival rate nearly doubles combining Inotuzumab with chemotherapy for adult patients with relapsed o...
Author: Cancer-News
Added: 08/30/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts